About ReviR Therapeutics
ReviR Therapeutics is a company based in San Francisco (United States) founded in 2021 by Yang Li. ReviR Therapeutics has raised $50 million across 4 funding rounds from investors including XtalPi, Tiantu Investment and Lapam Capital. ReviR Therapeutics offers products and services including REVIR Platform. ReviR Therapeutics operates in a competitive market with competitors including Moderna, BridgeBio, Spark Therapeutics, Alnylam and ATAI, among others.
- Headquarter San Francisco, United States
- Founders Yang Li
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$50 M (USD)
in 4 rounds
-
Latest Funding Round
Not available
-
Investors
XtalPi
& 9 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of ReviR Therapeutics
ReviR Therapeutics offers a comprehensive portfolio of products and services, including REVIR Platform.
Platform for AI-assisted RNA-based drug discovery processes.
People of ReviR Therapeutics
Unlock access to complete
Unlock access to complete
Funding Insights of ReviR Therapeutics
ReviR Therapeutics has successfully raised a total of $50M across 4 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in ReviR Therapeutics
ReviR Therapeutics has secured backing from 10 investors, including venture fund and institutional investors. Prominent investors backing the company include XtalPi, Tiantu Investment and Lapam Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Locked | Locked | Locked | |
|
Private equity and private debt firm focused on multiple sectors
|
Locked | Locked | Locked | |
|
A venture capital firm focused on technology and innovation investments.
|
Locked | Locked | Locked |
Investor details for ReviR Therapeutics
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by ReviR Therapeutics
Investment portfolio details for ReviR Therapeutics
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - ReviR Therapeutics
Detailed financials for ReviR Therapeutics
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Revir Therapeutics Comparisons
Peer comparison for ReviR Therapeutics
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of ReviR Therapeutics
ReviR Therapeutics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Moderna, BridgeBio, Spark Therapeutics, Alnylam and ATAI, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
mRNA-based therapeutics for diseases including cancer and infections are developed.
|
|
| Locked | Locked | Locked |
Therapeutics for genetic diseases are developed through targeted interventions.
|
|
| Locked | Locked | Locked |
Gene therapies for rare diseases including retinal dystrophies are developed.
|
|
| Locked | Locked | Locked |
RNA interference-based therapeutics are developed for multiple disorders.
|
|
| Locked | Locked | Locked |
A biopharmaceutical company accelerating innovative mental health treatments.
|
|
| Locked | Locked | Locked |
An AI-enabled platform is developed for infectious disease treatment.
|
Detailed competitors of ReviR Therapeutics
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Revir Therapeutics
Complete news archive for ReviR Therapeutics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about ReviR Therapeutics
ReviR Therapeutics was founded in 2021 and raised its 1st funding round 1 year after it was founded.
ReviR Therapeutics is headquartered in San Francisco, United States. It is registered at San Francisco, California, United States.
ReviR Therapeutics is a funded company, having raised a total of $50M across 4 funding rounds to date.
ReviR Therapeutics was established in 2021 in San Francisco, United States, within the biotechnology sector. RNA-based medicines are created for cancer, rare genetic disorders, and infectious diseases. Machine learning and advanced RNA methods are applied to support these efforts. Operations center on research and development to address unmet medical needs through targeted therapeutic approaches.
ReviR Therapeutics's top competitors include Moderna, Spark Therapeutics and BridgeBio.
ReviR Therapeutics offers REVIR Platform.
ReviR Therapeutics has 10 investors. Key investors include XtalPi, Tiantu Investment, Lapam Capital, CDH, and 5Y Capital.